Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating access restrictions to the ClinicalTrials.gov entry.SummaryDifference19%

- Check55 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the prior Revision: v3.6.5. This indicates an updated build of the page.SummaryDifference0.1%

- Check77 days agoChange DetectedAn error page is now served for the study record, replacing detailed study information with a generic message. This makes the study record inaccessible and removes key sections such as eligibility criteria, contacts, and locations from the view.SummaryDifference18%

- Check92 days agoChange DetectedThe page now shows Revision: v3.6.4 in the footer, replacing the previous Revision: v3.6.3. This indicates a small backend/content update to the page.SummaryDifference0.1%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.